[HTML][HTML] The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer
F Wang, F Jin, B Cheng, Y Zhang, Q Zhou… - Journal of Cancer …, 2022 - Springer
Purpose Anlotinib is an anti-angiogenetic multi-targeted tyrosine kinase inhibitor. This study
aimed to evaluate the efficacy and safety of anlotinib in advanced non-small cell lung cancer …
aimed to evaluate the efficacy and safety of anlotinib in advanced non-small cell lung cancer …
The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer
F Wang, F Jin, B Cheng, Y Zhang, Q Zhou… - Journal of Cancer …, 2022 - repository.ust.hk
Purpose: Anlotinib is an anti-angiogenetic multi-targeted tyrosine kinase inhibitor. This study
aimed to evaluate the efficacy and safety of anlotinib in advanced non-small cell lung cancer …
aimed to evaluate the efficacy and safety of anlotinib in advanced non-small cell lung cancer …
The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer
F Wang, F Jin, B Cheng, Y Zhang… - Journal of Cancer …, 2022 - search.proquest.com
Purpose Anlotinib is an anti-angiogenetic multi-targeted tyrosine kinase inhibitor. This study
aimed to evaluate the efficacy and safety of anlotinib in advanced non-small cell lung cancer …
aimed to evaluate the efficacy and safety of anlotinib in advanced non-small cell lung cancer …
[HTML][HTML] The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer
F Wang, F Jin, B Cheng, Y Zhang, Q Zhou… - Journal of Cancer …, 2022 - ncbi.nlm.nih.gov
Purpose Anlotinib is an anti-angiogenetic multi-targeted tyrosine kinase inhibitor. This study
aimed to evaluate the efficacy and safety of anlotinib in advanced non-small cell lung cancer …
aimed to evaluate the efficacy and safety of anlotinib in advanced non-small cell lung cancer …
The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer.
F Wang, F Jin, B Cheng, Y Zhang… - Journal of Cancer …, 2022 - search.ebscohost.com
Purpose: Anlotinib is an anti-angiogenetic multi-targeted tyrosine kinase inhibitor. This study
aimed to evaluate the efficacy and safety of anlotinib in advanced non-small cell lung cancer …
aimed to evaluate the efficacy and safety of anlotinib in advanced non-small cell lung cancer …
The Real-World Efficacy and Safety of Anlotinib in Advanced Non-Small Cell Lung Cancer
F Wang, F Jin, B Cheng, Y Zhang, Q Zhou, S Wang - 2021 - researchsquare.com
Purpose: Anlotinib is an anti-angiogenetic multi-targeted tyrosine kinase inhibitor. This study
aimed to evaluate the efficacy and safety of anlotinib in advanced non-small cell lung cancer …
aimed to evaluate the efficacy and safety of anlotinib in advanced non-small cell lung cancer …
The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer
F Wang, F Jin, B Cheng, Y Zhang… - Journal of cancer …, 2022 - pubmed.ncbi.nlm.nih.gov
Purpose Anlotinib is an anti-angiogenetic multi-targeted tyrosine kinase inhibitor. This study
aimed to evaluate the efficacy and safety of anlotinib in advanced non-small cell lung cancer …
aimed to evaluate the efficacy and safety of anlotinib in advanced non-small cell lung cancer …
The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer.
F Wang, F Jin, B Cheng, Y Zhang, Q Zhou… - Journal of Cancer …, 2021 - europepmc.org
Purpose Anlotinib is an anti-angiogenetic multi-targeted tyrosine kinase inhibitor. This study
aimed to evaluate the efficacy and safety of anlotinib in advanced non-small cell lung cancer …
aimed to evaluate the efficacy and safety of anlotinib in advanced non-small cell lung cancer …
The Real-World Efficacy and Safety of Anlotinib in Advanced Non-Small Cell Lung Cancer
F Wang, F Jin, B Cheng, Y Zhang, Q Zhou, S Wang - 2021 - europepmc.org
Purpose: Anlotinib is an anti-angiogenetic multi-targeted tyrosine kinase inhibitor. This study
aimed to evaluate the efficacy and safety of anlotinib in advanced non-small cell lung cancer …
aimed to evaluate the efficacy and safety of anlotinib in advanced non-small cell lung cancer …